SHORT TERM COMMON STOCK PURCHASE WARRANT ACCENTIA BIOPHARMACEUTICALS, INC.Security Agreement • March 28th, 2007 • Accentia Biopharmaceuticals Inc • Pharmaceutical preparations
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [ ] (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to the close of business on the earlier of (i) the 60th day following the later of (x) the Effective Date or (y) the date Shareholder Approval is received and effective or (ii) two year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from ACCENTIA BIOPHARMACEUTICALS, INC., a Florida corporation (the “Company”), up to [ ] shares (the “Warrant Shares”) of common stock, par value $.001 per share, of the Company (the “Common Stock”). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
8% CONVERTIBLE DEBENTURE DUE FEBRUARY 28, 2011Convertible Security Agreement • March 28th, 2007 • Accentia Biopharmaceuticals Inc • Pharmaceutical preparations • New York
THIS DEBENTURE is one of a series of duly authorized and validly issued 8% Convertible Debentures of ACCENTIA BIOPHARMACEUTICALS, INC., a Florida corporation, (the “Company”), having its principal place of business at 324 South Hyde Park Ave., Suite 350, Tampa, Florida 33606, designated as its 8% Convertible Debenture due February 28, 2011 (this debenture, the “Debenture” and, collectively with the other such series of debentures, the “Debentures”).
ContractSecurities Purchase Agreement • March 28th, 2007 • Accentia Biopharmaceuticals Inc • Pharmaceutical preparations
This Agreement (the “Agreement”), dated as of February 27, 2007, is by and among Accentia Biopharmaceuticals, Inc., a Florida corporation (the “Company”) and the investors signatory hereto (each, a “Purchaser” and collectively, the “Purchasers”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • March 28th, 2007 • Accentia Biopharmaceuticals Inc • Pharmaceutical preparations
This Registration Rights Agreement (this “Agreement”) is made and entered into as of February 27, 2007, among Accentia Biopharmaceuticals, Inc., a Florida corporation (the “Company”) and the several purchasers signatory hereto (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”).
